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Extracellular and intracellular copper and zinc regulate synaptic activity and plasticity,
which may impact brain functionality and human behavior. We have found that a metal
coordinating molecule, Neocuproine, transiently increases free intracellular copper and
zinc levels (i.e., min) in hippocampal neurons as monitored by Phen Green and FluoZin-
3 fluorescence, respectively. The changes in free intracellular zinc induced by Neocuproine
were abolished by the presence of a non-permeant copper chelator, Bathocuproine (BC),
indicating that copper influx is needed for the action of Neocuproine on intracellular Zn
levels. Moreover, Neocuproine decreased the mRNA levels of Synapsin and Dynamin,
and did not affect the expression of Bassoon, tubulin or superoxide dismutase (SOD).
Western blot analysis showed that protein levels of synapsin and dynamin were also down
regulated in the presence of Neocuproine and that these changes were accompanied
by a decrease in calcium transients and neuronal activity. Furthermore, Neocuproine
decreased the number of active neurons, effect that was blocked by the presence of
BC, indicating that copper influx is needed for the action of Neocuproine. We finally
show that Neocuproine blocks the epileptiform-like activity induced by bicuculline in
hippocampal neurons. Collectively, our data indicates that presynaptic protein configuration
and function of primary hippocampal neurons is sensitive to transient changes in transition
metal homeostasis. Therefore, small molecules able to coordinate transition metals and
penetrate the blood-brain barrier might modify neurotransmission at the Central Nervous
System (CNS). This might be useful to establish therapeutic approaches to control the
neuronal hyperexcitabiltity observed in brain conditions that are associated to copper
dyshomeotasis such as Alzheimer’s and Menkes diseases. Our work also opens a
new avenue to find novel and effective antiepilepsy drugs based in metal coordinating
molecules.
Keywords: copper, zinc, neocuproine, synaptic activity, dynamin, synapsin, hyperexcitability, epileptiform-like
activity
INTRODUCTION
Zinc (Zn) and copper (Cu) ions have a key physiological
importance in mammalian tissue (Mathie et al., 2006). Zn and
Abbreviations: BAPTA, 1,2-bis(o-aminophenoxy)ethane tetraacetate; BC,
bathocuproine; CNS, central nervous system; DMSO, dimethyl sulfoxide;
EDTA, Ethylenediaminetetraacetic acid; HEPES, 4-(2-hydroxyethyl)-
1-piperazineethanesulfonic acid; ROS, Reactive Oxygen Species; SOD,
Superoxide Dismutase; sPSCs, spontaneous postsynaptic currents; TPEN,
N,N,N,N′-tetrakis-(2-Pyridylmethyl)ethylenediamine; TTX, tetrodotoxin.
Cu are abundant trace elements in the human brain (Takeda
et al., 2001; Tarohda et al., 2004) and they participate in the
regulation of brain physiology, being key structural components
of several proteins and co-factors for enzymes that are critical
for brain function, including enzymes involved in antioxidant
defense and cellular respiration (Mathie et al., 2006). Increasing
evidence suggests that Zn and Cu ions function as signaling
molecules in the nervous system (Mathie et al., 2006). More-
over, these metals are released from the synaptic terminals of
certain neurons, affecting postsynaptic receptors and regulating
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neuronal excitability (Hartter and Barnea, 1988; Kardos et al.,
1989; Trombley and Shepherd, 1996; Vlachova et al., 1996;
Weiser and Wienrich, 1996; Hopt et al., 2003; Peters et al., 2011;
Opazo et al., 2014). Recently, some reports have described the
effects of Cu at the synaptic level, where it modulates complex
parameters such as LTP (Goldschmith et al., 2005; Gaier et al.,
2013, 2014a,b) and receptor pharmacology (Peters et al., 2011;
Marchetti et al., 2014). On the other hand, Zn has been con-
sidered to play a protective role, because zinc deficiency in the
diet can cause malfunctions of several organs and physiological
functions (Fukahori and Itoh, 1990). Zn-deficient animals display
abnormalities in behavior, which is associated to the deregula-
tion of Zn-binding ProSAP/Shank family members (Grabrucker
et al., 2014). In addition, Zn can regulate different intracel-
lular pathways that may explain the effect of Zn-deficiency in
brain development (Mackenzie et al., 2011; Nuttall and Oteiza,
2012).
Metal chelators are usually used to evaluate the effect of
metals on cell cultures (Calderaro et al., 1993; Göçmen et al.,
2000). For example, Neocuproine, a membrane permeable Cu (I)
chelator, has been frequently used as a protective agent against
oxidative stress caused by Cu (Calderaro et al., 1993). Moreover,
Neocuproine can inhibit the relaxation of electrically stimu-
lated mouse corpus cavernosum (Göçmen et al., 2000) and the
facilitation of bladder contraction induced by purinergic nerve
stimulation (Göçmen et al., 2005).
Considering that hippocampal formation is enriched in tran-
sition metals (Tarohda et al., 2004), we evaluated the effect
of Neocuproine on different synaptic parameters of primary
hippocampal cultures. We observed that Neocuproine acutely
increased intracellular Cu and Zn levels that lead to a concomitant
decrease in the number of active neurons, an effect which was
dependent of copper influx from the extracellular space. These
changes correlated with a decrease in levels of synapsin and
dynamin. Moreover, Neocuproine blocked the epileptiform-like
activity induced by bicuculline in hippocampal neurons. Thus,
the use of molecules that can modulate the free levels of Cu and
Zn ions could have potential roles on the physiopathology of
the central nervous system (CNS). For example, the information
presented in this paper can be useful to establish therapeutic
approaches to control hyperexcitability observed in brain con-
ditions associated to copper dyshomeostasis such as Alzheimer
and Menkes disease (Palop et al., 2003; Amatniek et al., 2006;
Prasad et al., 2011; Schrag et al., 2011; James et al., 2012).
This work also opens new venues to find novel and effective
antiepilepsy drugs (Cully, 2014) based in metal coordinating
molecules.
MATERIALS AND METHODS
PRIMARY CULTURES OF RAT HIPPOCAMPAL NEURONS
Hippocampal neurons were obtained from 18-day old pregnant
Sprague-Dawley rats and maintained for 10–14 days in vitro
(DIV) as previously described (Peters et al., 2011). Animals were
obtained from the animal house of Catholic University of Chile
(Santiago, Chile). All animals were handled in strict accordance
with NIH recommendations and approved by the appropriate
committee of University of Concepción (Concepción, Chile).
ELECTROPHYSIOLOGY
Experiments were performed in the “whole-cell” configura-
tion using the internal and external solutions described below.
Synaptic activity was recorded after a stable baseline was
reached. Recording pipettes were pulled from borosilicate glass
(WPI, Sarasota, FL) in a horizontal puller (Sutter Instruments,
Novato, CA). Membrane currents were measured using an
Axopatch-200B amplifier (Axon Instruments, Inc., Burlingame,
CA) and an inverted microscope (Nikon, Eclipse, TE200-U,
Japan). Data was collected, stored and analyzed using a data
acquisition system card (Axon Instruments, Inc.) and the
pClamp9 software (Axon Instruments, Inc.). For synaptic activ-
ity records, data was analyzed using the Minianalysis soft-
ware, obtaining the frequency, amplitude and decay time of
the records. All experiments were performed at room temper-
ature (20–25◦C) using a holding potential of −60 mV. Data
are given as means ± S.E.M. and are obtained from at least 3
experiments.
SOLUTIONS AND DRUGS
The intracellular medium contained (in mM): 120 KCl, 2 MgCl2,
2 ATP-Na2, 10 BAPTA, 0.5 GTP, 10 HEPES (pH 7.4). The extra-
cellular medium contained (in mM): 150 NaCl, 5.4 KCl, 2 CaCl2,
1 MgCl2, 10 glucose and 10 HEPES (pH 7.4).
IMMUNOFLUORESCENCE
Hippocampal cultures were grown in glass coverslips precoated
with poly-lysine (1%). After the treatments, hippocampal neu-
rons were washed with PBS (pH 7.4), and then fixed with
paraformaldehyde (4%) at RT for 10 min. Then, the dish
was washed again in PBS and neurons were permeabilized
and blocked for 30 min with PBST (PBS + triton 0.1%)
and BSA 10%. Then, cells were incubated with the follow-
ing primary antibodies for 16 h: Anti-synapsin and anti-MAP
2 antibody (Chemicon) were used in a 1:100 dilution. Sec-
ondary antibodies conjugated with FITC or Cy3 were used
for fluorescent staining (Jackson ImmunoResearch Laboratories,
PA). All of them were used at 1:500 for 2 h. Finally, sam-
ples were mounted in fluorescent mounting medium (DAKO,
CA, USA) and images were obtained under a Nikon Eclipse
confocal microscope (Nikon, Japan) (60×, water immersion,
NA 1.4).
RT-PCR
Total RNA was extracted from primary rat hippocampal cell cul-
tures using RNAsolv (Omega Biotek). Two µg of RNA were used
to prepare cDNA using Stratascript kit (Stratagene). PCR was
performed with specific forward and reverse primers (Genbank)
(Table 1), using 20–40 cycles in a Biorad Thermal Cycler.
WESTERN BLOT
Hippocampal cells were incubated with Neocuproine (0–30 µM),
culture media was removed and cells were washed with PBS and
then homogenized in sample buffer containing: SDS (4%), Glyc-
erol (12%), Phenol Red (0.0025%) and 10% β-mercaptoethanol
in Tris-HCl (450 mM, pH 8.45). 20 µl of each homogenate
(≈ 10 µg of total protein) was submitted to SDS electrophoresis
Frontiers in Aging Neuroscience www.frontiersin.org December 2014 | Volume 6 | Article 319 | 2
Castro et al. Neocuproine modulates synaptic activity
Table 1 | The list and sequence of primers used for RT-PCR analysis.
Protein Forward primer Reverse primer
Bassoon 5’-CCCCCAACCACTGCTAACTA-3’ 5’-CGAGCACAGAGGGGAAGTAG-3’
Snap29 5’-AGAGCTGTGGGCAGAGTGTT-3’ 5’-ACTCCATGCACACAAACCAA-3’
Synapsin 5’-CACCGACTGGGCAAAATACT-3’ 5’-TGTGCTGCTGAGCATCTCTT-3’
Dynamin I 5’-CAGGACAGGCCTCTTCACTC-3’ 5’-CCGATGTTGTTGATGGTCAG-3’
Dynamin II 5’-ACCCCACACTTGCAGAAAAC-3’ 5’-GGCTCTTTCAGCTTGACCAC-3’
Tubulin 5’-GCACTCTGATTGTGCCTTCA-3’ 5’-ACTGGATGGTACGCTTGGTC-3’
SOD1 5’-GTCGTCTCCTTGCTTTTTGC-3’ 5’-CACCTTTGCCCAAGTCATCT-3’
in 10–20% Tricine gels. Protein bands were transferred onto nitro-
cellulose membranes, blocked with 5% milk and incubated with
the following primary antibodies: monoclonal anti-synapsin,
anti-dynamin (1:500, Chemicon) and α-tubulin (1:1000, Sigma)
as internal control. Immunoreactive bands were detected with
secondary antibodies conjugated with HRP (Santa Cruz Biotech-
nology) and visualized with ECL Plus Western Blotting Detection
System (PerkinElmer).
ZN2+ AND CU2+INTRACELLULAR MEASUREMENTS
Hippocampal cells were loaded for 30 min at 37◦C with FluoZin-
3-AM (1 µM) or Phen Green (5 µM) (Invitrogen, USA) to
measure Zn2+ or Cu2+, respectively. Then, cells were washed
twice with external solution as described above and incubated
under control or experimental conditions for a maximal time of
30 min at 37◦C. Confocal images were acquired on middle cellular
plane, with 20× and 60×magnification. Intracellular fluorescent
signals were recorded with a CCD camera (SensiCam camera,
PCO, Germany), with 200 ms of exposition and 2 s acquisition
(Ex:Em; 490:510 nm).
ANALYSIS OF INTRACELLULAR CALCIUM TRANSIENTS
Hippocampal cells were loaded with Fluo-3 AM (1 µM in
pluronic acid/DMSO, Molecular Probes, Eugene, OR, USA) for
30 min at 37◦C and then washed twice with external solution,
as described above, and incubated under control or experimental
conditions for a maximal time of 30 min at 37◦C. Neurons
were mounted in a perfusion chamber that was placed on the
stage of an inverted fluorescent microscope (Eclipse TE, Nikon),
equipped with a CCD camera (SensiCam camera, PCO, Ger-
many) and xenon excitation lamp. Cells were subsequently excited
for 200 ms each 2 s intervals and recorded during 5 min, using
a Lambda 10-2 filter wheel (Sutter Instruments) and regions of
interest (ROI) were simultaneously selected on several neuronal
somata on each plate (Ex:Em; 480:510 nm) recording more
than 10 cells in each experiment. Finally, calcium transients, as
defined by their TTX sensitivity (Gu et al., 1994), were acquired
and analyzed off line with Axon Instruments Workbench 2.2
software.
DATA ANALYSIS
Results are expressed as the mean ± SEM. Statistical significance
was determined using One-way ANOVA. A level of ∗ p < 0.05,
∗∗ p < 0.01 and ∗∗∗ p < 0.001 was considered statistically
significant followed by the Bonferroni post test.
RESULTS
NEOCUPROINE INDUCES A COPPER-MEDIATED INTRACELLULAR ZINC
INCREASE
Zn and Cu may regulate the neurotransmission of CNS neurons
by a presynaptic or postsynaptic mechanism (Goldschmith et al.,
2005; Mathie et al., 2006; Leiva et al., 2009; Peters et al., 2011).
Therefore, pharmacological intervention with compounds that
change the balance of these metals at the neuronal level may
result in changes in synaptic function. To test this idea we exposed
primary rat hippocampal neurons (10–14 DIV) to Neocuproine
(Neo), a high affinity copper chelator (Göçmen et al., 2000).
First, we measured the changes of intracellular Cu using Phen
Green, a fluorescent probe that decreases its fluorescent signal
(quenching) when coordinates Cu (Chavez-Crooker et al., 2003).
As it was expected, neurons loaded with Phen Green under
control conditions displayed a stable basal fluorescent signal
(Figure 1A). However, when they were exposed to CuCl2 (3 µM),
the fluorescent signal was decreased, and a subsequent addition
of EDTA (10 µM) to the bath recovered the signal to the basal
levels (Figure 1A). Interestingly, when Neocuproine (10 µM) was
added alone to the bath, a small decrease in the intracellular
fluorescence was also observed, indicating that Neocuproine was
inducing an increase of free intracellular copper (Figure 1A). This
effect was observed in all neuronal cells exposed to Neocuproine
and the changes were detected both in soma and neuronal pro-
jections (Figures 1Bb,d). These results suggest that changes in
free intracellular Cu could be explained by a Cu influx from the
extracellular space, occurring at different cell membrane domains,
or by a Cu release from organelles or intracellular proteins,
which are widely distributed at the intracellular space. In order
to evaluate the effect of Neocuproine on the intracellular levels of
other transition metal, we performed similar experiments using
a specific fluorescent probe for Zn, FluoZin-3, which increases
its fluorescence signal in the presence of Zn (Sensi et al., 2011).
In fact, when Zn is co-applied with pyrithione (a Zn chelator)
(Pyr/Zn = 30/10 µM) a rapid increase was observed (Figure 1C),
which was abolished by a subsequent application of TPEN, a cell-
permeant Zn chelator (Sensi et al., 2011; Figure 1C). Interestingly,
when hippocampal cultures pre-loaded with Fluo-Zinc were
exposed to Neocuproine (10 µM), the fluorescent signal rapidly
increased (Figures 1D,E) in the soma and neuronal projections
(Zoom on Figure 1D). We confirmed that this signal was asso-
ciated with changes in free intracellular zinc, since the increase
in the fluorescent signal induced by Neocuproine was abolished
by a subsequent application of TPEN (Figure 1F). Therefore,
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FIGURE 1 | Neocuproine increases intracellular Zn2+ [Zn2+]i by
promoting copper influx in hippocampal neurons. (A) The traces
show the intracellular changes of Phen Green fluorescence after
extracellular acute application of CuCl2 (3 µM) (quenching), EDTA (10 µM)
(recovery) or Neocuproine (Neo, 10 µM) (quenching). Traces in color
correspond to the signal recorded in a single cell. The black trace
corresponds to the typical background signal recorded outside of cells.
(B) Confocal microphotographs of hippocampal cultures loaded with Phen
Green, untreated (a and c) or treated with Neo (10 µM) for 10 min (b and
d). Pseudocolor images shown in “c” and “d”, correspond to fluorescence
photographs shown in “a” and “b”, respectively. Bar represents 100 µm.
(C) The traces show the intracellular changes of FluoZin-3 fluorescence
under control conditions or after the acute application of the agents
indicated in the figure (Pyr/Zn = 30/10 µM; TPEN = 10 µM). Each trace
corresponds to the signal recorded in a single cell. (D) Confocal
microphotographs of hippocampal cultures loaded with FluoZin-3, before
(time = 0) and after of a short application (up to 8 min) of Neo (10 µM).
Scale bar, 250 µm. At the right of this panel is shown a confocal zoom of
two neurons from the experiment described in “(D)”. The graph
summarizes the intracellular Zn2+ changes recorded in the soma of single
neurons treated as shown in “(D)”. Values are mean ± SEM (N = 3). (E)
The traces show the rapid intracellular changes of FluoZin-3 fluorescence
after the acute application of Neocuproine (Neo, 10 µM). (F–H) Each
colored trace corresponds to the FluoZin-3 fluorescent signal recorded on
the soma of single hippocampal neuron under the treatments indicated in
the figures (Neocuproine, Neo = 10 µM; Bathocuproine, BC = 10 µM;
TPEN = 10 µM). The black traces correspond to the typical background
signal recorded outside of cells.
Neocuproine increases simultaneously free intracellular Cu and
Zn. Considering that Neocuproine has a higher affinity for Cu
than Zn and also that the application of Neocuproine was at
the bath solution, we hypothesized that Neocuproine facilitated
the entry of copper from the extracellular space, which in turns
displaced Zn from intracellular reservoirs. To test this hypoth-
esis, we evaluated the effect of Bathocuproine (BC), a selective
non cell-permeant Cu chelator (Mohindru et al., 1983), on the
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intracellular Zn changes induced by Neocuproine. In agreement
with this hypothesis, we found that the presence of BC com-
pletely abolished the changes in Zn levels induced by Neocuproine
(Figure 1G), indicating that Neocuproine facilitates the influx of
copper, which then allows the rise of free intracellular Zn. We
confirmed that BC itself was not changing the basal levels of intra-
cellular Zn (Figure 1H). Altogether, these results indicate that it
is possible to modify free intracellular Zn levels by using specific
molecules that facilitate copper influxes from the extracellular
space.
ACUTE APPLICATION OF NEOCUPROINE DOES NOT AFFECT SYNAPTIC
ACTIVITY
To evaluate if rapid intracellular changes in Cu and Zn induced by
Neocuproine affects neurotransmission, we studied the synaptic
activity of neurons under the same experimental conditions.
Spontaneous calcium transients were recorded in the presence of
the Fluo3-AM probe, allowing us to assess the changes on intra-
cellular calcium as a reflection of synaptic and neuronal network
activity (Peters et al., 2011). We observed no significant differ-
ences between control and acutely Neocuproine-treated neurons
(Figure 2A). Moreover, when we evaluated the electrophysiolog-
ical synaptic activity of these neurons by whole cell patch clamp
recordings, the result correlated with calcium signals, since no dif-
ferences were observed between control and Neocuproine-treated
neurons (Figure 2B), in the frequency (control, 2.4 ± 0.6 Hz;
Neocuproine, 2.5 ± 0.3 Hz) (Figure 2C) or amplitude (control,
280 ± 38 pA; Neocuproine, 190 ± 47 pA) (Figure 2D) of the
currents. The patch clamp recordings also indicated that the
FIGURE 2 | Acute application of Neocuproine does not alter synaptic
transmission. (A) Calcium transients of hippocampal neurons in the
absence or presence of Neocuproine (Neo, 10 µM). (B) Typical miniature
synaptic currents obtained in the absence or presence of Neocuproine
(Neo, 10 µM). The graphs summarize the frequency (C) and the amplitude
(D) values of miniature synaptic currents recorded in three independent
experiments performed under the conditions described in “(B)”. In both
cases values are mean ± SEM (N = 3).
FIGURE 3 | Chronic application of Neocuproine decreases the number
of active neurons. (A) The top traces show typical calcium transients
observed in active hippocampal neurons in culture. The bottom traces show
the lack of calcium transients in inactive hippocampal neurons in culture.
Each trace corresponds to the signal recorded in a single cell. (B) The graph
summarizes the percentage of active hippocampal neurons under different
treatments: untreated (control) or treated with Neocuproine (Neo, 10 µM) in
the absence or presence of Bathocuproine (BC, 10 µM) for 12 h. Values are
mean ± SEM (N = 3). **, p < 0.01.
control and Neocuproine-treated neurons presented an active
neurotransmission.
SUB-CHRONIC APPLICATION OF NEOCUPROINE DECREASES THE
NUMBER OF ACTIVE NEURONS
To analyze if Neocuproine could induce changes in synaptic
activity after sub-chronic incubations, hippocampal cultures were
exposed to Neocuproine (10 µM) for 12 h and then the synaptic
activity was evaluated measuring calcium transients. We found
that the number of active neurons was decreased in the presence of
Neocuproine, and that the effect was inhibited by the presence of
BC in the cell media (Figures 3A,B), indicating that Neocuproine
decreased the synaptic activity by a mechanism involving copper
entry from the extracellular space.
SUB-CHRONIC APPLICATION OF NEOCUPROINE DOWN-REGULATES
SYNAPSIN AND DYNAMIN
We reasoned that the reduction on the number of active neurons
after the treatment with Neocuproine should be accompanied
with changes in the machinery responsible for neurotransmis-
sion, including scaffold and synaptic proteins. First, we analyzed
the mRNA levels of dynamin I, dynamin II, synapsin, Bassoon,
SNAP29, Superoxide Dismutase (SOD) and tubulin in rat hip-
pocampal cultures treated in the absence or presence of 10 µM
Neocuproine for 12 h. We found that the mRNA of dynamin
(I and II) and synapsin, but not the mRNA of Bassoon and
SNAP29 were decreased. We also did not observe changes in
SOD or tubulin mRNA levels (Figure 4A). Then, hippocam-
pal cultures were incubated with increasing concentrations of
Neocuproine (up to 30 µM) for 12 h. Under these condi-
tions protein levels for dynamin I and synapsin (Figures 4B–D)
were decreased in the presence of Neocuproine in a concen-
tration dependent manner. A similar pattern was also observed
by immunofluorescence analysis (Figure 5A), indicating that
Neocuproine decreased the signal of specific synaptic proteins
such as synapsin. To evaluate if the change in synapsin levels
induced by Neocuproine was also mediated by the uptake of
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FIGURE 4 | Chronic application of Neocuproine down-regulates
synapsin and dynamin. (A) mRNA levels of dynamin I (dyI), dynamin
II (dyII), synapsin, Bassoon (Bas), SNAP29, Superoxide Dismutase
(SOD) and Tubulin (Tub) expressed by rat hippocampal cultures (11 DIV)
treated in the absence or presence of Neocuproine (Neo, 10 µM) for
12 h. Values are mean ± SEM (N = 3). *, p < 0.05. (B) Protein levels of
synapsin and dynamin I expressed by rat hippocampal cultures (11
DIV) treated in the absence or presence of Neo (up to 30 µM) for 12 h.
Whole brain homogenate (H) of 15 days post-natal rat was used as
positive control. (C,D) The graphs summarize the data obtained in
experiments described in “(B)”. Values are mean ± SEM (N = 3).
*, p < 0.05; **, p < 0.01.
copper from the extracellular media, we performed experiments
in the presence of BC (Figures 5B,C). In agreement with this
hypothesis, BC blocked the effect Neocuproine on synapsin levels,
indicating that copper uptake was critical for the decrease in
synapsin levels.
NEOCUPROINE BLOCKS THE EPILEPTIFORM-LIKE ACTIVITY INDUCED
BY BICUCULLINE IN HIPPOCAMPAL NEURONS
Considering that Neocuproine modulates neurotransmission
we evaluated whether Neocuproine down-regulates the
epileptiform-like activity in hippocampal neurons. To evaluate
the chronic effect of Neocuproine on the neuronal activity we
used whole cell patch clamp technique (−60 mV) and measured
miniature postsynaptic currents in primary hippocampal neurons
treated with bicuculline for 24 h, which induce epileptiform-like
activity in neurons (Carrasco et al., 2007; Sepúlveda et al., 2009).
As shown in Figure 6, we found that the frequency of miniature
postsynaptic currents was significantly lower after chronic
administration (24 h) of Neocuproine (10 µM) compared to
control (Control, 0.352 ± 0.045 Hz, n =12 vs. Neocuproine,
0.125 ± 0.016 Hz, n = 11; p < 0.01). However, no significant
differences were observed in the amplitude of the miniature
postsynaptic currents (control, 35.81 ± 5.22 pA, n = 12 vs.
Neocuproine, 22.08 ± 3.72 pA, n = 11). These results correlate
with the decrease in the number of active neurons (Figure 3)
and the decrease on the levels of presynaptic proteins dynamin
(I and II) and synapsin observed after sub-chronic treatments
with Neocuproine (Figure 4). Interestingly, chronic treatments
with Neocuproine blocked the epileptiform-like activity induced
by bicuculline (5 µM; 24 h) (Figure 6; Control, 0.352± 0.045 Hz,
n = 12; bicuculline, 0.744 ± 0.104; Neocuproine + bicuculline
0.197± 0.047; Neocuproine, 0.125± 0.016 Hz, n = 11; p< 0.01),
suggesting that Neocuproine can abolish epileptogenic-like
activity in CNS neurons.
DISCUSSION
Zn and Cu are abundant trace elements involved in the regulation
of human brain physiology (Takeda et al., 2001; Tarohda et al.,
2004), being key structural components of several proteins and
co-factors for enzymes that are critical for brain function (Mathie
et al., 2006). In fact, increasing evidence suggests that Zn and
Cu ions function as signaling molecules in the nervous system
(Mathie et al., 2006). Moreover, these metals are released from
the synaptic terminals of certain CNS neurons, affecting post-
synaptic receptors and regulating neuronal excitability (Hartter
and Barnea, 1988; Kardos et al., 1989; Trombley and Shepherd,
1996; Vlachova et al., 1996; Weiser and Wienrich, 1996; Hopt
et al., 2003; Peters et al., 2011; Sensi et al., 2011). Therefore,
pharmacological strategies that interfere the homeostasis of these
transition metals may modulate synaptic function. In this regard,
this is the first time that Neocuproine, a high affinity copper
chelator (Göçmen et al., 2000), is shown to decrease synaptic
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FIGURE 5 | Bathocuproine blocks the decrease of synapsin
induced by Neocuproine treatments. (A) Microphotographs of rat
hippocampal neurons treated with Neocuproine (Neo, 10 µM and 30
µM) for 12 h. Synapsin immunoreactivity is shown in green, and
MAP2 in red. Scale bar, 25 µm. (B) Protein levels of synapsin
expressed by rat hippocampal cultures (11 DIV) treated in the
absence or presence of Neo (up to 30 µM), and Neo (10 µM) +
Bathocuproine (BC, 10 µM) for 12 h. (C) The graph summarize the
data obtained in the experiment described in “(B)”. Values are mean
± SEM (N = 3). * p < 0.05.
activity in hippocampal neurons (Figure 3), by a mechanism
that involves the influx of Cu from the extracellular space that
in turn induces the subsequent mobilization of intracellular Zn
from proteins and/or organelles that were not identified in this
study. According to our results, the presence of BC, a selective
non cell-permeant Cu chelator (Mohindru et al., 1983), com-
pletely abolished the changes in the intracellular Zn levels induced
by Neocuproine (Figure 1), indicating Neocuproine facilitated
the influx of copper, which subsequently drove the rise of free
intracellular Zn. In our working hypothesis, after Neocuproine-
Cu complexes get across the plasma membrane Neocuproine
donates Cu to Zn-proteins that interchange Zn and Cu in the
intracellular space, thus releasing the Zn to the cytosol. We
hypothesized that the rise of Zn induced by Neocuproine is occur-
ring through a competitive mechanism. However, we could not
discard that Neocuproine-Cu complexes or free Cu donated by
Neocuproine-Cu complexes can inhibit, at the extra/intracellular
space, Zn pumps or active Zn transporters that explain the rise
in cytosolic Zn (Sensi et al., 2011). Moreover, all these changes
in Cu and Zn homeostasis could promote the formation of
reactive oxygen species (ROS), which may also participate in the
regulation of synaptic proteins. We believe that our experimental
conditions do not favor the formation of toxic levels of ROS,
because the neuronal viability was not affected in the presence
of Neocuproine. We acknowledge that different results can be
expected in neuronal viability if exogenous Cu is added to the
media, because it has been show that Neocuproine-Cu complexes
are toxic to cultured astrocytes (Chen et al., 2008). However, we
can not ruled out that non-toxic levels of ROS were produced
in the presence of Neocuproine. Therefore, future studies are
needed to better understand the mechanisms behind the effect
of Neocuproine on living neurons, which may lead to establish
protocols to change the neuronal activity. This information may
be useful to prevent or to treat copper-related neurodegenerative
diseases and neurological conditions, which remain untreatable
to date (Bush, 2003). Interestingly, the effect of Neocuproine on
free intracellular Cu and Zn was observed in cells maintained
in cell media that was not supplemented with extra Cu or Zn
and contained in total 1 µM of total Cu. Altogether, these results
indicate that it is possible to modify the free intracellular Zn levels
by using specific molecules that facilitate copper influxes from the
extracellular space under basal conditions. These results also sug-
gest that the alteration of the homeostasis of one transition metal
can affect the homeostasis of another for a simple mechanism of
competition.
We further found that the number of active neurons was
decreased in primary cultures treated with Neocuproine, which
was blocked by the presence of BC in the cell media (Figure 3),
indicating that Neocuproine decreased the synaptic activity by a
mechanism that involves the entry of copper to the cell from the
extracellular space. Interestingly, the reduction on the number
of active neurons after the treatment with Neocuproine was
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FIGURE 6 | Neocuproine blocks the epileptiform-like activity
induced by bicuculline in hippocampal neurons. (A) Representative
traces of miniature postsynaptic currents illustrate the effect of control
and chronic (24 h) bicuculline (5 µM) treatment in the absence or
presence of Neocuproine (Neo, 10 µM) in hippocampal neurons. (B,C)
The graphs summarize the effect of the different treatments on the
frequency (Hz) and amplitude (pA) of the records obtained in three
independent experiments performed under the conditions described in
“(A)”. Values are mean ± SEM obtained from the indicated number of
neurons. ***, p < 0.001.
accompanied with changes in synapsin and dynamin I, both
important proteins in the presynaptic machinery responsible for
neurotransmission, through a direct or indirect mechanism that
may lead to a reduction in neurotransmitter release. For example,
Zn, Cu or Neocuproine-Cu complexes could directly interact
with these proteins, decreasing their protein stabilities or/and
their synthesis or/and increasing their degradation by the pro-
teasome (Colledge et al., 2003). Because, we have recently found
that Neocuproine does not change the ubiquitination pattern
of neuronal cells (data not shown), a mechanism involving the
ubiquitin-proteasome system can be partially ruled out, suggest-
ing that the down-regulation effect of Neocuproine on dynamin
and synapsin might be explained by changes in protein expres-
sion. All these possible mechanisms deserve further examination.
In this regard, a protein involved in synaptic vesicle dynamic,
SV2A, has been recently found to be an effective target for epilepsy
(Gillard et al., 2011) supporting the presynapse as a target to
control hyperexcitability.
In summary, in this work we have shown that Neocuproine,
in time, concentration and copper dependent manner promotes
changes on neurotransmission, suggesting that changes in tran-
sition metal might be required by neuronal cells to maintain
adequate synaptic function (Peters et al., 2011). In fact, an
increase in the brain concentration of copper, as well as a decrease
in the levels of this metal, can lead to serious illness (Bush,
2003). Interestingly, Neocuproine blocks the epileptiform-like
activity induced by bicuculline in hippocampal neurons, sug-
gesting that Neocuproine might be a prototype drug to con-
trol the hyperexcitability observed in brain disorders such as
Alzheimer and Menkes disease (Palop et al., 2003; Amatniek
et al., 2006; Prasad et al., 2011), which are also characterized
by brain copper dyshomeostasis (Schrag et al., 2011; James
et al., 2012). Our data suggest that Neocuproine blocks the
epileptiform-like activity by reducing the levels of synapsin and
dynamin. However, we can not discard the participation of other
presynaptic and postsynaptic targets that may be involved in the
effect of Neocuproine on synaptic activity. Further ex vivo and
in vivo studies are needed to confirm that Neocuproine is really
effective to control hyperexcitability in humans. The origin of
the brain overexcitation in these diseases is not well understood,
but it might be related to changes in brain bioavailable copper.
Interestingly, Tg2576 mice that overexpress APP and have lower
levels of brain copper (Maynard et al., 2002) are more susceptible
to chemical-induced seizures (Westmark et al., 2008), suggest-
ing an association between brain copper homeostasis and brain
overexcitation.
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